Business Context and Reporting Period
This Form 8-K Current Report was filed by Disc Medicine, Inc. (Nasdaq: IRON) on April 19, 2023, covering events occurring on April 18, 2023. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
The primary material change reported is the resignation of Jay T. Backstrom, M.D., M.P.H., from the Board of Directors. His resignation is effective as of the close of business on June 9, 2023.
Management Commentary and Risks
- Reason for Departure: Dr. Backstrom is resigning to focus on his role as Chief Executive Officer of Scholar Rock Holdings Corporation.
- Disagreement Status: Management explicitly states that the resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.
- Outlook: No financial guidance or operational outlook is provided in this filing.
Investor Verification Checklist
- Confirm the effective date of Dr. Backstrom's resignation (June 9, 2023).
- Verify if the Board has initiated a search for a replacement director.
- Review the Company's recent 10-K or 10-Q filings for the most current financial position, as this 8-K contains no financial data.
- Monitor future filings for any changes in corporate strategy resulting from the Board composition change.